Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2441781
Max Phase: Preclinical
Molecular Formula: C53H88N2O17
Molecular Weight: 1025.28
Molecule Type: Unknown
Associated Items:
ID: ALA2441781
Max Phase: Preclinical
Molecular Formula: C53H88N2O17
Molecular Weight: 1025.28
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]3OC(=O)c3ccccc3)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
Standard InChI: InChI=1S/C53H88N2O17/c1-18-36-53(11,62)44(59)29(4)39(56)27(2)25-51(9,63-16)45(71-49-41(58)35(54(12)13)24-28(3)65-49)30(5)42(31(6)47(60)68-36)69-37-26-52(10,64-17)46(33(8)66-37)72-50-43(38(55(14)15)40(57)32(7)67-50)70-48(61)34-22-20-19-21-23-34/h19-23,27-33,35-38,40-46,49-50,57-59,62H,18,24-26H2,1-17H3/t27-,28-,29+,30+,31-,32-,33+,35+,36-,37+,38+,40-,41-,42+,43-,44-,45-,46+,49+,50+,51+,52-,53-/m1/s1
Standard InChI Key: VTZORXTZSSNEHA-QHKOUZCMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1025.28 | Molecular Weight (Monoisotopic): 1024.6083 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhu D, Xu Y, Liu Y, Chen X, Zhao Z, Lei P.. (2013) Synthesis of 4″-O-desosaminyl clarithromycin derivatives and their anti-bacterial activities., 23 (23): [PMID:24139585] [10.1016/j.bmcl.2013.09.083] |
Source(1):